CDC-RFA-GH16-1721Rev.pdf

Centers for Disease Control

Center for Global Health

Polio Eradication and Emergency Response in Priority Countries

CDC-RFA-GH16-1721

Application Due Date: 06/15/2016

Signature Date

Polio Eradication and Emergency Response in Priority Countries

CDC-RFA-GH16-1721

TABLE OF CONTENTS

Part I. Overview Information Federal Agency NameA.

Funding Opportunity TitleB.

Announcement TypeC.

Agency Funding Opportunity NumberD.

Catalog of Federal Domestic Assistance (CFDA) NumberE.

Dates F.

Executive Summary G.

Part II. Full Text Funding Opportunity Description A.

Award Information B.

Eligibility Information C.

Application and Submission Information D.

Review and Selection Process E.

Award Administration Information F.

Agency Contacts G.

Other Information H.

Glossary I.

Part I. Overview Information Applicants must go to the synopsis page of this announcement at www.grants.gov and click on the "Send Me Change Notifications Emails" link to ensure they receive notifications of any changes to CDC-RFA-GH16-1721. Applicants also must provide an e-mail address to www.grants.gov to receive notifications of changes.

A. Federal Agency Name:

Centers for Disease Control and Prevention (CDC) / Agency for Toxic Substances and Disease Registry

(ATSDR)

B. Funding Opportunity Title:

Polio Eradication and Emergency Response in Priority Countries C. Announcement Type: New - Type 1 This announcement is only for non-research activities supported by CDC. If research is proposed, the application will not be considered. For this purpose, research is defined at https://www.gpo.gov/fdsys/pkg /CFR-2007-title42-vol1/pdf/CFR-2007-title42-vol1-sec52-2.pdf. Guidance on how CDC interprets the definition of research in the context of public health can be found at http://www.cdc.gov/od/science/integrity /docs/cdc-policy-distinguishing-public-health-research-nonresearch.pdf.

Non-research

D. Agency Funding Opportunity Number:

CDC-RFA-GH16-1721

E. Catalog of Federal Domestic Assistance (CFDA) Number:

93.185 F. Dates:

1. Due Date for Letter of Intent (LOI): N/A

2. Due Date for Applications: 06/15/2016, 11:59 p.m. U.S. Eastern Standard Time, at www.grants.gov.

3. Date for Informational Conference Call:

N/A

G. Executive Summary:

1. Summary Paragraph:

Purpose: Support the governments of polio endemic and high-risk countries to achieve polio eradication in 2016-2018 and provide for post-eradication sustaining efforts.

Strategies:

Support polio campaign activities in security compromised and inaccessible areas of polio endemic and high risk countries.

Improve training and supervision of polio eradication initiative (PEI) activities in high risk districts of polio endemic countries and in at-risk regions of countries that border endemic countries.

Inactivated Polio Vaccine (IPV) catch-up vaccination of children < 5 years of age in low-performing districts of polio endemic and high risk countries.

Outcomes:

Increased access to children with polio vaccine in the insecure and inaccessible areas of polio endemic https://foa.grantsolutions.gov/www.grants.gov https://foa.grantsolutions.gov/www.grants.gov https://www.gpo.gov/fdsys/pkg/CFR-2007-title42-vol1/pdf/CFR-2007-title42-vol1-sec52-2.pdf https://www.gpo.gov/fdsys/pkg/CFR-2007-title42-vol1/pdf/CFR-2007-title42-vol1-sec52-2.pdf http://www.cdc.gov/od/science/integrity/docs/cdc-policy-distinguishing-public-health-research-nonresearch.pdf http://www.cdc.gov/od/science/integrity/docs/cdc-policy-distinguishing-public-health-research-nonresearch.pdf http://www.grants.gov and high risk countries.

Improved quality of polio campaigns in low-performing, high risk districts or LGAs of polio endemic countries and in at-risk regions of countries that border endemic and high risk countries.

Improved IPV coverage among children < 5 years of age in polio endemic and high risk countries.

a. Eligible Applicants: Single

b. FOA Type: Cooperative Agreement

c. Approximate Number of Awards: 1

d. Total Project Period Funding: $2,000,000

e. Average One Year Award Amount: $0 There is not an award ceiling. However, funding is estimated to be $500,000 per 6 month budget period.

f. Total Project Period Length: 2

g. Estimated Award Date: 07/15/2016

h. Cost Sharing and / or Matching Requirements:

N

No

Part II. Full Text A. Funding Opportunity Description

1. Background

a. Overview Eradicating polio in 2016 is a high priority for the US government and the global community. Nigeria, Afghanistan and Pakistan are the only three countries where polio remains endemic. The most recent Independent Monitoring Board (IMB) report indicated that failure to eradicate polio in 2016 is a threat to the global program, would cost ~ $1.5 billion a year for every year of delay, and likely result in the exportation of polio to neighboring countries. WHO has established the polio end game strategy over the next five years which is dependent on interruption of transmission in the remaining polio endemic countries in 2016, and on increasing surveillance and routine immunization activities in high risk districts/regions of non-endemic neighboring countries.

Currently, polio eradication programs in Nigeria, Pakistan and Afghanistan are using a whole of government approach to achieve eradication. The programs have established a presidential task force and activated Emergency Operation Centers to implement and monitor activities. Multiple partners are working with the Emergency Operation Center (EOC) including Rotary International, WHO, UNICEF, Bill and Melinda Gates Foundation, USAID and others.

Support for the program in insecure areas of each of the three countries have been inadequate in terms of the quality of campaigns and limited access for vaccination teams. These countries cannot eradicate polio without improving the quality of campaigns in the insecure areas. Specifically, the Afghan Polio program has requested emergency assistance from IFRC and the Afghanistan Red Crescent Society (ARCS) for emergency support for program activities in the insecure areas of Nangarhar, Helmand, and Kandahar provinces. These are the provinces with ongoing polio transmission and the main reservoirs of polio virus in Afghanistan. ARCS has volunteers and ongoing health activities in most of the very high risk (Priority 1 LPDs) and high risk (Priority 2 LPDs) districts. IFRC and its movement partners (ICRC and ARCS) are uniquely qualified to support polio eradication activities as outlined in the proposal.

There are similar problems with access for polio vaccination activities in the insecure and tribal areas of Pakistan and in the insecure areas of northeastern Nigeria, as well as in the border areas of countries in the

Pakistan and in the insecure areas of northeastern Nigeria, as well as in the border areas of countries in the Lake Chad basin that border Nigeria (Cameroon, Chad, Niger, Central African Republic). Working with the Pakistan Red Crescent Society (PRCS), grantee will support oral polio vaccination (OPV) and IPV Catch-up vaccination in the high risk districts in Pakistan. In Northeast Nigeria, IFRC and the Nigerian Red Cross (NRCS) will work with partners to conduct enhanced community-based surveillance (CBS) and response to priority diseases and conditions among children younger than five, in communities in hard to access and newly liberated areas of Borno state. IFRC will also work with partners in Cameroon, Chad, Niger, and Central African Republic to develop and implement strategies to reach and vaccinate children < 5years in remote, insecure, difficult to reach areas, as well as in nomadic populations during routine immunizations and supplementary immunization activities.

b. Statutory Authorities Section 307 of the PHS Act (42 U.S.C. 242); section 317(k)(1) and (2) of the PHS Act (42 U.S.C. 247b(k)(1) and (2)).

c. Healthy People 2020 Healthy People 2020 goals for immunization and infectious diseases are rooted in evidence-based clinical and community activities and services for the prevention and treatment of infectious diseases. Objectives new to Healthy People 2020 focus on technological advancements and ensuring that States, local public health departments, and nongovernmental organizations (NGOs) are strong partners in the Nation’s attempt to control the spread of infectious diseases. Awareness of disease and completing prevention and treatment courses remain essential components for reducing infectious disease transmission. http://www.healthypeople .gov/2020/topics-objectives/topic/global-health.

d. Other National Public Health Priorities and Strategies This FOA will support the US Government endorsed Global Polio Eradication Initiative (GPEI) and the Global Immunization Vision and Strategy (GIVS), 2006-2015. http://www.polioeradication.org/Aboutus /Governance/PolioOversightBoard.aspx

e. Relevant Work CDC is supporting work in IFRC through secondment of a medical officer to the IFRC office in Geneva. In addition, CDC supports ongoing GPEI activities in Afghanistan through cooperative agreements with UNICEF under CDC-RFA-GH13-1302 and WHO under CDC-RFA-GH13-1301. This grant will build on the efforts of WHO and UNICEF by addressing communities that are not accessed through their efforts.

2. CDC Project Description

a. Approach

Bold indicates project period outcome.

Strategies and Activities in polio endemic countries and countries in the Lake Chad Region

Short-term Outcomes

Intermediate Outcomes

Long-Term Outcomes http://www.healthypeople.gov/2020/topics-objectives/topic/global-health http://www.healthypeople.gov/2020/topics-objectives/topic/global-health http://www.polioeradication.org/Aboutus/Governance/PolioOversightBoard.aspx http://www.polioeradication.org/Aboutus/Governance/PolioOversightBoard.aspx

Support for polio campaign activities in low-performing districts

Increase supervision of polio campaign in low-performing districts

Implement community-based surveillance for priority diseases in hard-to-reach LGAs with NRCS access in Borno state

IPV catch-up campaigns among children < 5 years of age living in low-performing districts

Cross border coordination to support polio eradication

Outreach to underserved communities in low-performing districts

Improve delivery of routine infant immunizations to low-performing polio districts

Increased vaccination coverage among children living in insecure and inaccessible areas

Improved quality of polio campaigns

Facilitate rapid case investigation and response to suspected cases of infectious diseases with epidemic potential

Increased polio immunity among children < 5 years of age living in low-performing districts

Coordination in vaccination delivery along Pakistan and Afghan borders, and along the borders of countries in the Lake Chad Basin

Improved polio vaccination among migratory and underserved populations

Increased routine infant vaccination coverage

Improved polio immunity among children living in low-performing districts.

Increased vaccination coverage among children in low-performing districts

Support access to essential health services and commodities

Decreased circulation of polio virus

Decreased wild polio virus circulation among high-risk populations

Prevention of cross-border transmission of wild polio virus

Increased number of polio vaccine doses given to children through routine infant immunization

Improved polio immunity in low-performing districts leading to polio eradication

Population-based immunity leading to polio eradication

Improved health outcomes by facilitating basic primary care services for the most vulnerable people

Prevention of polio reservoirs among hard to reach mobile populations

Increased routine infant vaccination coverage.

Polio eradication

i. Purpose This FOA will support the governments of polio endemic countries and other polio high risk areas and

This FOA will support the governments of polio endemic countries and other polio high risk areas and countries to achieve polio eradication between 2016-2018 and provide for post-eradication sustaining efforts.

Grantee will work in partnership with ARCS and its extensive network of volunteers to reach children in security compromised and inaccessible areas of polio endemic countries and high risk areas with potentially life-saving polio vaccines.

ii. Outcomes Short-term Outcomes

• Increased vaccination coverage among children living in insecure and inaccessible areas

• Improved quality of polio campaigns

• Increased polio immunity among children < 5 years of age living in low-performing districts

• Coordination in vaccination delivery along Pakistan and Afghan borders, and along the borders of the countries of the Lake Chad Basin region (Nigeria, Chad, Cameroon, Niger, Central African Republic)

Intermediate Outcomes

• Improved polio immunity among children < 5 years of age living in low-performing districts

• Increased vaccination coverage among children in low-performing districts

• Decreased circulation of poliovirus in core polio reservoirs of Afghanistan, Pakistan and Nigeria

• Decreased poliovirus circulation among high risk populations – the migrant and hard-to-reach populations of Afghanistan, Pakistan, and Nigeria

Progress to be made within the 2 year grant period

1. Short-term Outcomes

• Improved polio vaccination among migratory and underserved populations

• Increased routine infant vaccination coverage

2. Intermediate Outcomes

• Prevent cross-border transmission of wild poliovirus between Afghanistan and Pakistan and between Northeast Nigeria (Borno, Adamawa, Yobe States) and neighboring countries in the Lake Chad Basin Region (Chad, Cameroon, Niger, Central African Republic)

• Increased number of polio vaccine doses given to children through routine infant immunization

3. Long-term Outcomes

• Interrupt endemic circulation of wild poliovirus

• Achieve population immunity to wild poliovirus.

• Prevent persistence of polio reservoirs among hard-to-reach and mobile populations of Nigeria, Afghanistan and Pakistan

• Increased routine infant vaccination coverage in all 3 countries and the countries in the Lake Chad Region

• Polio eradication

iii. Strategies and Activities Support for polio campaign activities in low-performing districts: Grantee will recruit and train local red cross society volunteers such as the ARCS and the NRCS who will serve as social mobilizers and work in teams to vaccinate children <5 years of age against polio in high-risk districts of polio-endemic countries and at-risk neighboring countries. Their activities will target security compromised and inaccessible areas of selected districts with evidence of ongoing or at high-risk of wild poliovirus transmission.

1.

a. Identify the underserved and hard-to-reach populations in Chad, Cameroon, Central African Republic, and Niger by conducting assessments such as the equity assessment. This activity requires the use of informal channels and collaboration with community leaders (traditional healers, religious and opinion leaders, others), local volunteers, and NGOs active in the community. Local ethnic and religious leaders should be involved to help understand and overcome barriers (cultural, educational, logistical, political, language, or religious) that prevent caregivers from bringing their children for immunization (e.g. adjustment of time for daily immunization activities) and to help in planning and social mobilization.

2. Implement community-based surveillance for priority conditions and diseases in hard-to-reach LGAs with NRCS access in Borno state through weekly reporting to wards and LGA focal points: In Borno State, Nigeria, Grantee will recruit local community members to identify priority health needs and facilitate the response to those needs in order to improve health outcomes by facilitating basic primary care services for the most vulnerable people. Grantee will partner with the Nigeria Red Crescent Society to identify and report new cases of the six identified conditions or diseases (see table below) to the LGA level. The CBS project will be based on the Red Cross Red Crescent’s community-based health and first aid (CBHFA) approach, which prioritises community engagement and empowers volunteers and their communities to take charge of their own health.

a. Facilitate rapid case investigation and response to suspected cases of infectious diseases with epidemic potential: Grantee will engage community volunteers to identify possible cases of polio or measles in low performing districts and communities. Upon identification of a possible case, the Red Cross divisional programme manager/divisional secretary will trigger appropriate responses by the Red Cross and/or other agencies, based on access to and security in the community in question. Grantee will work with the volunteer in the affected community to identify strategies to investigate suspect cases.

b. Support access to essential health services and commodities: In Borno State, Nigeria and in Chad, Central African Republic, and Niger, Grantee will provide Red Cross volunteers with primary health kits to respond to health needs within their communities as outlined in the table below.

Table. Detection, management and case investigation of priority conditions in Borno State, Nigeria

Condition Management Case investigation

Severe diarrhea Oral rehydration, zinc, Weekly reporting aggregate, stool sample for community with > 2 cases

Suspect malaria Rapid diagnostic tests (RDT), artemisinin-based combination therapy (ACT) (infant, and child)

Weekly reporting, aggregate numbers

Measles Case investigation, vitamin A, referral for severe cases

Weekly, case-based data

AFP Support case investigation Immediate reporting and referral

Severe undernutrition If referral is not possible, treatment in the community with ready-to-use therapeutic foods (RUTF)

Weekly reporting

ARI IMCI treatment recommendation

Weekly reporting

3. Increase supervision of polio campaigns in low-performing districts/LGAs: Grantee will recruit and train supervisors, who will manage teams of polio vaccinators as they work to access and conduct quality supplementary immunization activities in insecure and inaccessible areas

Of the Eastern and Southern regions of Afghanistan at high-risk of wild poliovirus transmission, In Northeast Nigeria, especially in Borno, Yobe, and Adamawa States Along the border regions of countries in the Lake Chad Basin

4. IPV Catch-up campaigns among children < 5 years of age living in low-performing districts: Children living in high-risk districts of polio-endemic countries and at-risk neighboring countries with recent (<12 months) evidence of wild poliovirus transmission or areas which have not been accessible for polio campaigns for >12 months will be targeted for special catch-up vaccination campaigns using IPV, which has been shown to boost population immunity to polio.

5. Cross border coordination to support polio eradication: Grantee will recruit ARCS/NRCS and other applicable red cross society volunteers who will liaise with cross-border teams between Afghanistan and Pakistan on the Eastern and Southern borders of Afghanistan;

between Borno, Adamawa, and Yobe States in Northeast Nigeria and the other countries of the Lake Chad Basin (Chad, Cameroon, Niger, Central African Republic)

The volunteers will work to strengthen links between teams working on both sides of the national borders, with a view to improving coordination and information sharing.

6. Outreach to underserved communities in low-performing districts: Volunteers will be constituted into special mobile teams that will track and vaccinate children under five years of age among migrant and hard-to-reach communities of Afghanistan, Pakistan, Nigeria, and in the countries within the Lake Chad Basin Region (Cameroon, Chad, Niger, and Central African Republic). The teams will develop and maintain registers of children in these communities to track their vaccination status and ensure they are adequately immunized against polio.

7. Improve delivery of routine infant immunizations to low-performing polio districts: High risk communities will be targeted for routine immunization strengthening in order to improve the quality of service delivery. This will be done through staff recruitments in areas with understaffed facilities, training of existing staff and local capacity-building on supervision and monitoring for highly experienced staff.

1. Collaborations

a. With other CDC programs and CDC-funded organizations:

Awardee is required to collaborate with CDC Global Immunization Division (GID), UNICEF, and WHO country teams.

b. With organizations not funded by CDC:

Awardee may collaborate with other organizations external to CDC as deemed necessary to achieve project outcomes. Organizations include: Bill and Melinda Gates Foundations (BMGF), USAID, GAVI, Rotary International, International Committee of the Red Cross (ICRC) and/or other organizations.

2. Target Populations Children in low-performing districts at high-risk of poliovirus transmission in Eastern and Southern regions

Children in low-performing districts at high-risk of poliovirus transmission in Eastern and Southern regions of Afghanistan as well as neighboring areas of Pakistan; in the security compromised and newly liberated areas of Borno, Adamawa and Yobe States, in Northeast Nigeria; and along the borders of Nigeria and the other countries of the Lake Chad Basin, including Niger, Cameroon, Chad, and Central African Republic.

a. Inclusion FOA requires grantee collaboration with local Red Cross/Red Crescent Societies who will utilize local volunteers to conduct outreach to underserved communities in low-performing districts: special mobile teams will track and vaccinate children under five years of age among migrant and hard-to-reach communities of Afghanistan. The teams will develop and maintain registers of children in these communities to track their vaccination status and ensure they are adequately immunized against polio. The use of volunteers from within the underserved community will assure language does not impede inclusion.

Federal disability rights laws apply to foreign assistance programs. Funded programs consider including people with disabilities in all aspects of the program (e.g., advisory boards, planning committees, project staff, consultants, etc.), and ensure to best of their ability that persons with disabilities are not discriminated against in hiring processes, and that facilities and communications are accessible.

iv. Funding Strategy N/A

b. Evaluation and Performance Measurement

i. CDC Evaluation and Performance Measurement Strategy Evaluation Question: Has engagement of grantee through ARCS volunteers increased access to and vaccination of children against polio in security compromised and inaccessible areas of low-performing districts of Afghanistan?

Performance Evaluation (See Table)

Outcomes Performance Measures Data Sources

Process Measures Outcome Measures

Short Term Outcomes

Increased vaccination coverage among children living in insecure and inaccessible districts

- Number of vaccination teams recruited in each district

- Number of trainings conducted for vaccinators in each district

Number of microplanning meetings held before each vaccination campaign

- Number previously inaccessible districts in which campaigns were conducted

- Number of children vaccinated against polio in each district

- Number of children vaccinated for the first time against polio

- Country reports

- Partner reports

- Campaign planning reports

- Intra- and post-campaign monitoring data

Improved quality of polio campaigns in security compromised areas

Number of supervisors and monitors recruited

Number of trainings conducted for supervisors

Number of districts where intra- and post-campaign monitoring were conducted

Percentage of districts with >80% coverage

Percentage of children fingermarked in each district

Percentage of districts that achieved a “pass” by lot quality assurance sampling

(LQAS)

Country reports

Partner reports

Campaign planning reports

Intra- and post-campaign monitoring data

Improved case investigation and response to suspected cases of infectious diseases with epidemic potential

- Number of community volunteers recruited in each LGA

Number of trainings conducted for community volunteers

Number of health facilities visited by community volunteers

Number of cases of polio and measles reported, including zero-case reporting

Percentage of volunteers submitting weekly surveillance reports

Percentage of health facilities reported as non-functioning, partially functioning, and functioning

- Partner reports

Country reports

Weekly surveillance reports

Improved cross-border coordination between Country PEI teams in low-performing, high risk districts

Number of cross-border coordination meetings held monthly in each district

Percentage of low-performing districts submitting monthly cross-border activity reports

Country reports

Partner reports

Cross-border reports

Intermediate Term Outcomes

Increased population immunity to polio

Number of doses of OPV administered to children in insecure districts during each campaign

Number of doses of IPV administered to children in insecure districts during each campaign

Number of districts reporting no wild poliovirus cases in following first six months of project implementation

Absence of orphan viruses from districts targeted for project implementation

Country reports

Partner reports

Weekly surveillance reports

Laboratory reports

Long-term Outcomes

Interrupt endemic circulation of wild poliovirus in Afghanistan, Nigeria and Pakistan

Number of polio supplementary immunization activities conducted in security compromised districts

Absence of wild poliovirus cases for 12 months following first full year of project implementation

Country reports

Partner reports

Vaccination campaign data

Weekly surveillance reports

PEI

certification reports

Increase routine infant vaccination coverage

Number of EPI staff hired and trained

Number of EPI supervisor trainings held annually

Percentage of districts with >80% OPV3 and DTP3 coverage

Percentage of districts reporting decreased dropout rates from previous year’s levels

National EPI coverage data

EPI coverage survey reports

Partner reports

ii. Applicant Evaluation and Performance Measurement Plan Applicants must provide an evaluation and performance measurement plan that demonstrates how the awardee will fulfill the requirements described in the CDC Evaluation and Performance Measurement and Project Description sections of this FOA. At a minimum, the plan must describe:

How applicant will collect the performance measures, respond to the evaluation questions, and use evaluation findings for continuous program quality improvement.

How key program partners will participate in the evaluation and performance measurement planning processes.

Available data sources, feasibility of collecting appropriate evaluation and performance data, and other relevant data information (e.g., performance measures proposed by the applicant).

Where the applicant chooses to, or is expected to, take on specific evaluation studies, they should be directed to:

Describe the type of evaluations (i.e., process, outcome, or both).

Describe key evaluation questions to be addressed by these evaluations.

Describe other information (e.g., measures, data sources).

Awardees will be required to submit a more detailed Evaluation and Performance Measurement plan within the first 6 months of award, as described in the Reporting Section of this FOA.

c. Organizational Capacity of Awardees to Implement the Approach Eligible applicant must have demonstrated experience and collaboration in the following areas:

Collaboration in public health programs with priority country national governments Collaboration with multiple polio eradication partners including BMGF, USAID, WHO, UNICEF, Rotary and others Collaboration with movement partners IFRC, ARCS NRCS,and other country-specific Red Cross society volunteers who will negotiate for safe access in insecure areas Demonstrated accomplishments in designing and implementing public health action and programs in complex settings Demonstrated capacity to mobilize sufficient culturally competent personnel to achieve outcomes Ability to manage grants and contracts

d. Work Plan The work plan allows the CDC Project Officer to monitor implementation of activities and progress on project period outcomes. Applicants should provide a high-level work plan that covers the duration of the project with more detail for the first year of the project period. The work plan must include, at minimum:

Activities and timelines to support achievement of FOA outcomes. These activities must be in alignment with the FOA Logic Model and have appropriate performance measures or milestones for accomplishing tasks Staff and administrative roles and functions to support implementation of the award Monitoring and evaluation plan to determine quality and effectiveness of program activities within each country

A suggested work plan format is provided below. If using this format, the table should be completed for each project period outcome. If a particular activity leads to multiple outcomes, it should be described under each outcome measure.

Project Period Outcome:

[from Outcomes section and/or logic model]

Outcome Measure:

[from Evaluation and Performance

Measurement section]

Strategies and Activities Process Measure

[from Evaluation and Performance

Measurement section]

Responsible

Position /Party

Completion Date

1.

2.

3.

4.

5.

6.

e. CDC Monitoring and Accountability Approach Monitoring activities include routine and ongoing communication between CDC and awardees, site visits, and awardee reporting (including work plans, performance, and financial reporting). Consistent with applicable grants regulations and policies, CDC expects the following to be included in post-award monitoring for grants and cooperative agreements:

Tracking awardee progress in achieving the desired outcomes.

Ensuring the adequacy of awardee systems that underlie and generate data reports.

Creating an environment that fosters integrity in program performance and results.

Monitoring may also include the following activities:

Ensuring that work plans are feasible based on the budget and consistent with the intent of the award.

Ensuring that awardees are performing at a sufficient level to achieve outcomes within stated timeframes.

Working with awardees on adjusting the work plan based on achievement of outcomes, evaluation results and changing budgets.

Monitoring performance measures (both programmatic and financial) to assure satisfactory performance levels.

Other activities deemed necessary to monitor the award, if applicable.

These activities may include monitoring and reporting activities that assist grants management staff (e.g., grants management officers and specialists, and project officers) in the identification, notification, and management of high-risk grantees.

f. CDC Program Support to Awardees (THIS SECTION APPLIES ONLY TO COOPERATIVE

AGREEMENTS)

CDC Activities:

Organize an orientation meeting with the grantees to discuss applicable U.S. Government, HHS, and other key management requirements, as well as financial and program reporting formats and contents.

Meet on a bi-annual basis with the grantee to assess expenditures and program progress in relation to approved work plan and Evaluation and Performance Measurement Plan and modify plans, as necessary.

Meet on bi-annual basis with the grantee to review budget period progress report and budgets for the subsequent year.

Monitor implementation of supported activities, and the use of funding during the collaboration period.

Recommend approval for the grantee’s annual work plan, detailed budget and monitoring and evaluation plan.

Provide assistance and technical consultation on all aspects of design, program planning, implementation, monitoring and evaluation, and coordination between components and activities as needed.

Provide consultation and scientific assistance based on appropriate HHS/CDC documents to promote the use of best practices known at the time.

Provide in-country administrative support through short temporary duty assignments (TDY) to assist the grantee meet U.S. Government financial and reporting requirements approved by the Office of Management and Budget (OMB) under 0920-0428 (Public Health Service Form 5161).

Assist in establishing partnerships that will build global public health capacity and increase field support.

Assist in the preparation and implementation of training and conferences.

Provide technical assistance or advice on any data collections on 10 or more people that are planned or conducted by the awardee. All such data collections-- where CDC staff will be or are approving, directing, conducting, managing, or owning data-- must undergo OMB project determinations by CDC and may require OMB PRA clearance prior to the start of the project

B. Award Information

1. Funding Instrument Type: Cooperative Agreement CDC's substantial involvement in this program appears in the CDC Program

CDC's substantial involvement in this program appears in the CDC Program Support to Awardees Section.

2. Award Mechanism: U2G

3. Fiscal Year: 2016

4. Approximate Total Fiscal Year Funding:

$500,000

5. Approximate Project Period Funding:

$2,000,000

This amount is subject to the availability of funds.

Estimated Total Funding: $2,000,000

6. Total Project Period Length:

2 year(s)

7. Expected Number of Awards:

8. Approximate Average Award:

$0 Per Budget Period

There is not an award ceiling. However, funding is estimated to be $500,000 per 6 month budget period.

9. Award Ceiling: $0 Per Budget Period

This amount is subject to the availability of funds.

10. Award Floor: $0 Per Budget Period

11. Estimated Award Date: 07/15/2016

12. Budget Period Length: 6 month(s)

Throughout the project period, CDC will continue the award based on the availability of funds, the evidence of satisfactory progress by the awardee (as documented in required reports), and the determination that continued funding is in the best interest of the federal government. The total number of years for which federal support has been approved (project period) will be shown in the “Notice of Award.” This information does not constitute a commitment by the federal government to fund the entire period. The total project period comprises the initial competitive segment and any subsequent non-competitive continuation award(s).

13. Direct Assistance Direct Assistance (DA) is not available through this FOA.

C. Eligibility Information

1. Eligible Applicants Eligibility Category: Others (see text field entitled "Additional Information on Eligibility" for clarification)

Additional Eligibility Category:

2. Additional Information on Eligibility

The International Federation of Red Cross and Red Crescent Societies (IFRC) Route de Pre-Bois, 1, 1214 Vernier, Geneva, Switzerland

3. Justification for Less than Maximum Competition The International Federation of Red Cross and Red Crescent Societies(IFRC) is the world's largest humanitarian organization, providing assistance without discrimination as to nationality, race, religious beliefs, class or political opinions. Founded in 1919, the IFRC comprises 190 member Red Cross and Red Crescent National Societies, a secretariat in Geneva and more than 60 delegations strategically located to support activities around the world. Through the national societies, the Afghan Red Crescent Society, for example, the IFRC possesses the unique ability to access remote areas of the world where wild polio virus is still being transmitted, such as Nigeria, Afghanistan and Pakistan. On-going polio transmission and the main reservoirs of polio virus are located in the complex settings such as the insecure Afghan provinces of Nangahar, Helmand and Khandahar or the countries in the Lake Chad Basin Region, or the Nigerian States of Borno, Yobe, and Adamawa which are affected by the Boko Haram insurgency and the resulting humanitarian crisis. Polio cannot be eradicated without improving the campaigns in these areas and the Afghan government has requested emergency assistance from IFRC. This organization already provides on-going health activities in most of these areas, which are inaccessible to Americans due to State Department prohibitions, which other nations are also enforcing on their citizens, making this region inaccessible. The polio high transmission season begins in May. Successful interruption of transmission is dependent upon providing support to IFRC to increase activities as close to the beginning of the high transmission season as is possible. IFRC is the only organization with the necessary access to these regions. Disapproval will delay the administration of life-saving polio vaccines, put nearly 41,000 children under the age of 5 at risk for polio infection and likely result in the exportation of polio to neighboring countries. Further, disapproval would delay the world-wide eradication of Polio by years, resulting in additional efforts by numerous partners in the eradication effort around the world as well as additional costs which are estimated by the Independent Monitoring Board at $1.5 billion per year for every year of delay.

4. Cost Sharing or Matching Cost Sharing / Matching Requirement:

No

No

5. Maintenance of Effort Maintenance of effort is not required for this program.

D. Application and Submission Information

1. Required Registrations An organization must be registered at the three following locations before it can submit an application for funding at www.grants.gov.

a. Data Universal Numbering System:

All applicant organizations must obtain a Data Universal Numbering System (DUNS) number. A DUNS number is a unique nine-digit identification number provided by Dun & Bradstreet (D&B). It will be used as the Universal Identifier when applying for federal awards or cooperative agreements.

The applicant organization may request a DUNS number by telephone at 1-866-705-5711 (toll free) or internet at http:// fedgov.dnb. com/webform/ displayHomePage.do. The DUNS number will be provided at no charge.

http://www.grants.gov/ http://fedgov.dnb.com/webform/displayHomePage.do

If funds are awarded to an applicant organization that includes sub-awardees, those sub-awardees must provide their DUNS numbers before accepting any funds.

b. System for Award Management (SAM):

The SAM is the primary registrant database for the federal government and the repository into which an entity must submit information required to conduct business as an awardee. All applicant organizations must register with SAM, and will be assigned a SAM number. All information relevant to the SAM number must be current at all times during which the applicant has an application under consideration for funding by CDC.

If an award is made, the SAM information must be maintained until a final financial report is submitted or the final payment is received, whichever is later. The SAM registration process can require 10 or more business days, and registration must be renewed annually. Additional information about registration procedures may be found at www.SAM.gov.

c. Grants.gov:

The first step in submitting an application online is registering your organization at www.grants.gov, the official HHS E-grant Web site. Registration information is located at the “Get Registered” option at www.grants.gov.

All applicant organizations must register at www.grants.gov. The one-time registration process usually takes not more than five days to complete. Applicants should start the registration process as early as possible.

Step System Requirements Duration Follow Up

1 Data Universal Number System

(DUNS)

1. Click on http://fedgov.dnb.com/webform

2. Select Begin DUNS search/request process

3. Select your country or territory and follow the instructions to obtain your DUNS 9-digit #

4. Request appropriate staff member(s) to obtain DUNS number, verify & update information under DUNS number

1-2 Business Days

To confirm that you have been issued a new DUNS number check online at (http://fedgov.dnb.com/webform) or call 1-866-705-5711

2 System for Award Management

(SAM)

formerly Central Contractor Registration

(CCR)

1. Retrieve organizations DUNS number

2. Go to www.sam.gov and designate an E-Biz POC (note CCR username will not work in SAM and you will need to have an active SAM account before you can register on grants.gov)

3-5 Business Days but up to 2 weeks and must be renewed once a year

For SAM Customer Service Contact https://fsd.gov/fsd-gov/home.do Calls:

866-606-8220

3 Grants.gov 1. Set up an individual account in Grants.gov using organization new DUNS number to become an authorized organization representative (AOR)

2. Once the account is set up

Same day but can take 8 weeks to be fully registered and

Register early! Log into grants.gov and check AOR status until it shows you have been approved https://www.sam.gov/portal/public/SAM/ http://grants.gov/ http://www.grants.gov/ http://www.grants.gov/ http://www.grants.gov/ http://fedgov.dnb.com/webform http://fedgov.dnb.com/webform http://www.sam.gov https://fsd.gov/fsd-gov/home.do the E-BIZ POC will be notified via email

3. Log into grants.gov using the password the E-BIZ POC received and create new password

4. This authorizes the AOR to submit applications on behalf of the organization approved in the system (note, applicants

MUST

obtain a

DUNS

number and SAM account before applying on grants.gov)

2. Request Application Package Applicants may access the application package at www.grants.gov.

3. Application Package Applicants must download the SF-424, Application for Federal Assistance, package associated with this funding opportunity at www.grants.gov. If Internet access is not available, or if the online forms cannot be accessed, applicants may call the CDC OGS staff at 770-488-2700 or e-mail OGS ogstims@cdc.gov for assistance. Persons with hearing loss may access CDC telecommunications at TTY 1-888-232-6348.

4. Submission Dates and Times If the application is not submitted by the deadline published in the FOA, it will not be processed. Office of Grants Services (OGS) personnel will notify the applicant that their application did not meet the deadline.

The applicant must receive pre-approval to submit a paper application (see Other Submission Requirements section for additional details). If the applicant is authorized to submit a paper application, it must be received by the deadline provided by OGS.

a. Letter of Intent Deadline (must be emailed or postmarked by) Due Date for Letter of Intent: N/A

b. Application Deadline Due Date for Applications: 06/15/2016 , 11:59 p.m. U.S. Eastern Standard Time, at www.grants.gov. If Grants.gov is inoperable and cannot receive applications, and circumstances preclude advance notification of an extension, then applications must be submitted by the first business day on which grants.gov operations resume.

Date for Information Conference Call

N/A

5. CDC Assurances and Certifications All applicants are required to sign and submit “Assurances and Certifications” documents indicated at http://wwwn.cdc.gov/ grantassurances/ (S(mj444mxct51lnrv1hljjjmaa)) /Homepage.aspx.

Applicants may follow either of the following processes:

Complete the applicable assurances and certifications with each application submission, name the file “Assurances and Certifications” and upload it as a PDF file with at www.grants.gov http://www.grants.gov http://www.grants.gov mailto:ogstims@cdc.gov http://www.grants.gov http://wwwn.cdc.gov/grantassurances/(S(mj444mxct51lnrv1hljjjmaa))/Homepage.aspx

Complete the applicable assurances and certifications and submit them directly to CDC on an annual basis at http://wwwn.cdc.gov/ grantassurances/ (S(mj444mxct51lnrv1hljjjmaa))/ Homepage.aspx

Assurances and certifications submitted directly to CDC will be kept on file for one year and will apply to all applications submitted to CDC by the applicant within one year of the submission date.

6. Content and Form of Application Submission Applicants are required to include all of the following documents with their application package at www.grants.gov.

7. Letter of Intent LOI is not requested or required as part of this application.

8. Table of Contents (There is no page limit. The table of contents is not included in the project narrative page limit.): The applicant must provide, as a separate attachment, the “Table of Contents” for the entire submission package.

Provide a detailed table of contents for the entire submission package that includes all of the documents in the application and headings in the "Project Narrative" section. Name the file "Table of Contents" and upload it as a PDF file under "Other Attachment Forms" at www.grants.gov.

9. Project Abstract Summary (Maximum 1 page) A project abstract is included on the mandatory documents list and must be submitted at www.grants.gov.

The project abstract must be a self-contained, brief summary of the proposed project including the purpose and outcomes. This summary must not include any proprietary or confidential information. Applicants must enter the summary in the "Project Abstract Summary" text box at www.grants.gov.

10. Project Narrative (Maximum of 20 pages, single spaced, 12 point font, 1-inch margins, number all pages. Content beyond 20 pages will not be reviewed. The 20 page limit includes the work plan.)

Applicants must submit a Project Narrative with the application forms. Applicants must name this file “Project Narrative” and upload it at www.grants.gov. The Project Narrative must include all of the bolded headings shown in this section. The Project Narrative must be succinct, self-explanatory, and in the order outlined in this section. It must address outcomes and activities to be conducted over the entire project period as identified in the CDC Project Description section. Failure to follow the guidance and format may negatively impact scoring of the application.

a. Background Applicants must provide a description of relevant background information that includes the context of the problem (See CDC Background).

b. Approach

i. Purpose Applicants must describe in 2-3 sentences specifically how their application will address the public health problem as described in the CDC Background section.

http://www.grants.gov http://wwwn.cdc.gov/grantassurances/(S(mj444mxct51lnrv1hljjjmaa))/Homepage.aspx http://www.grants.gov http://www.grants.gov http://www.grants.gov

ii. Outcomes Applicants must clearly identify the outcomes they expect to achieve by the end of the project period, as identified in the logic model in the Approach section of the CDC Project Description. Outcomes are the results that the program intends to achieve and usually indicate the intended direction of change (e.g., increase, decrease).

iii. Strategies and Activities Applicants must provide a clear and concise description of the strategies and activities they will use to achieve the project period outcomes. Applicants must select existing evidence-based strategies that meet their needs, or describe in the Applicant Evaluation and Performance Measurement Plan how these strategies will be evaluated over the course of the project period. See the Strategies and Activities section of the CDC Project Description.

1. Collaborations Applicants must describe how they will collaborate with programs and organizations either internal or external to CDC.

Applicant is encouraged to upload MOU or MOA and/or Letters of Support as appropriate, naming the file “MOU/MOAs” and/or “Letters of Support” respectively and upload as a PDF file at www.grants.gov.

2. Target Populations Applicants must describe the specific target population(s) in their jurisdiction and explain how such a target will achieve the goals of the award and/or alleviate health disparities. Refer back to the Target Population section in the CDC Project Description.

a. Inclusion: Applicants must address how they will include specific populations who can benefit from the program, refer back to the CDC Project Description section – Approach: Inclusion

c. Applicant Evaluation and Performance Measurement Plan Applicants must provide an evaluation and performance measurement plan that demonstrates how the awardee will fulfill the requirements described in the CDC Evaluation and Performance Measurement and Project Description sections of this FOA. At a minimum, the plan must describe:

How applicant will collect the performance measures, respond to the evaluation questions, and use evaluation findings for continuous program quality improvement. The Paperwork Reduction Act of 1995 (PRA): Applicants are advised that any activities involving information collections (e.g., surveys, questionnaires, applications, audits, data requests, reporting, recordkeeping and disclosure requirements) from 10 or more individuals or non-Federal entities, including State and local governmental agencies, and funded or sponsored by the Federal Government are subject to review and approval by the Office of Management and Budget. See Section E (pages 4 and 5) at http://www.hhs.gov/sites/default/files/grants/grants/policies-regulations/hhsgps107.pdf . For further information about CDC’s requirements under PRA see http://www.hhs.gov/ ocio/policy/collection/.

How key program partners will participate in the evaluation and performance measurement planning processes.

Available data sources, feasibility of collecting appropriate evaluation and performance data, and other relevant data information (e.g., performance measures proposed by the applicant).

Where the applicant chooses to, or is expected to, take on specific evaluation studies, they should be directed to:

Describe the type of evaluations (i.e., process, outcome, or both).

Describe key evaluation questions to be addressed by these evaluations.

Describe other information (e.g., measures, data sources).

http://www.grants.gov http://www.hhs.gov/sites/default/files/grants/grants/policies-regulations/hhsgps107.pdf http://www.hhs.gov/ocio/policy/collection/

Describe other information (e.g., measures, data sources).

Awardees will be required to submit a more detailed Evaluation and Performance Measurement plan within the first 6 months of award, as described in the Reporting…